Presentation of the research results of the Kazakh Version of the MDS-UDysRS on an International Platform

Abdraimova Saltanat Orynbasarovna participated in the International Congress on Parkinson’s Disease and Movement Disorders, which took place from September 27 to October 1, 2024, in Philadelphia, USA. At this significant international scientific event, Abdraimova S.O. presented a poster titled "Validation of the Kazakh Version of the Movement Disorder Society-Unified Dyskinesia Rating Scale," highlighting important aspects of Parkinson's disease.
The aim of the study was to validate the Kazakh version of the Movement Disorder Society's Dyskinesia Rating Scale (MDS-UDysRS). This research aimed to create an officially approved Kazakh version of the MDS-UDysRS scale. The official English UDysRS scale was translated into Kazakh and then back into English by two independent translation groups. Preliminary cognitive testing of the Kazakh version was conducted, and necessary adjustments were made to the structure and wording of the translation. The final Kazakh version was applied to 250 patients with Parkinson's disease experiencing levodopa-induced dyskinesias. For all four sections of the Kazakh-language MDS-UPDRS questionnaire, the Comparative Fit Index (CFI) compared to the standard was 0.94. Factor analysis revealed some differences between the two datasets; however, these differences were deemed acceptable for native Kazakh speakers. The results indicate that the Kazakh translation of the MDS-UDysRS has adequate clinimetric properties. It has been approved as the official translation and can be reliably used in the Kazakh-speaking population.
The International Congress on Parkinson’s Disease and Movement Disorders is one of the key platforms for exchanging scientific knowledge and discussing recent advancements in movement disorders. Participation in such an event provides a unique opportunity for interaction with leading scientists and specialists, sharing experiences, and forming new scientific and professional connections.
Abdraimova S.O., a doctoral student and assistant at the Department of Neurology, Psychiatry with a course in Rehabilitation and Neurosurgery, stated: "It was a great honor for me to present our results at such a significant International Congress, supported by a travel grant. Our research, conducted under the guidance of Prof. Zharkinbekova N.A. and PhD Dr. Kairzhanov R.B., aimed at providing qualified medical care to patients with Parkinson’s disease according to world standards, and we are confident that the findings will contribute to the further development of neurology as a whole."
The International Congress on Parkinson's Disease and Movement Disorders was held from September 27 to October 1, 2024, in Philadelphia, USA. The number of participants was 4,800 from over 100 countries, with a total of 107 oral presentations and 1,800 poster presentations. There were 250 recipients of travel grants.